David Apelian
Vorstandsvorsitzender bei EIGER BIOPHARMACEUTICALS, INC.
Vermögen: 94 337 $ am 30.04.2024
Aktive Positionen von David Apelian
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| EIGER BIOPHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 14.06.2017 | - |
| Vorstandsvorsitzender | 15.12.2022 | - | |
| Geschäftsführer | 03.01.2018 | 14.06.2019 | |
| Technik-/Wissenschafts-/F&E-Leiter | 03.01.2018 | 14.06.2019 |
Karriereverlauf von David Apelian
Ehemalige bekannte Positionen von David Apelian
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
BlueSphere Bio, Inc.
 BlueSphere Bio, Inc. Pharmaceuticals: MajorHealth Technology BlueSphere Bio, Inc. manufactures oncology drugs products. The company was founded by Mark Shlomchik, Warren Shlomchik, and Constantinos Panousis and is headquartered in Pittsburgh, PA. | Direktor/Vorstandsmitglied | 01.07.2019 | 04.10.2022 |
| Vorstandsvorsitzender | 01.07.2019 | 04.10.2022 | |
| ACHILLION PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 30.05.2013 | 28.12.2017 |
| GLOBEIMMUNE, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2008 | 01.01.2013 |
| BRISTOL-MYERS SQUIBB COMPANY | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2002 | - |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1999 | - |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Corporate Officer/Principal | - | - |
Ausbildung von David Apelian
| Rutgers State University of New Jersey | Doctorate Degree |
| Quinnipiac University | Masters Business Admin |
| University of Medicine & Dentistry of New Jersey | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 10 |
| Frankreich | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 5 |
| Doctorate Degree | 2 |
| Director/Board Member | 2 |
Sektoral
| Health Technology | 8 |
| Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| GLOBEIMMUNE, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
BlueSphere Bio, Inc.
BlueSphere Bio, Inc. Pharmaceuticals: MajorHealth Technology BlueSphere Bio, Inc. manufactures oncology drugs products. The company was founded by Mark Shlomchik, Warren Shlomchik, and Constantinos Panousis and is headquartered in Pittsburgh, PA. | Health Technology |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Health Technology |
- Börse
- Insiders
- David Apelian
- Erfahrung
